Diagnostic Outcomes Monitoring Executive Summary (DOMES) report
Overview
The Diagnostic Outcomes Monitoring Executive Summary (DOMES) report is a high level summary of
key treatment information provided in an easy to read ‘at a glance’ format. It provides
benchmarking against national figures and also against averages for groups of similar partnerships
(clusters). This gives context to the figures observed and aids ambition setting.
Direction of travel arrows and graphs specific to each partnership’s figures put current performance
in context of previous quarters without needing to look at previous quarters’ reports. The report is
also used as a mechanism for NTA local teams to provide feedback to partnerships.
Investment
Financial information in this section is derived from treatment plans and puts performance into a
financial context.
Successful Completions
Increasing successful completions from treatment is an important factor in measuring recovery. This
section of the report provides an overview of performance in this key area. There are three elements
reported, all segmented by opiate and non-opiate users: successful completions as a proportion of
the overall treatment population, re-presentations to treatment and percentage growth since
baseline. Successful completion data for Criminal Justice clients is also presented in this section:
successful completions as a proportion of the overall treatment population and re-presentations to
treatment are both reported.
This section is further supported by a suite of successful completions reports which provide more indepth analysis.
Effective Treatment
Clients being ‘retained in effective treatment’ (for at least 12 weeks or successfully completing
before that time) remains an important indicator, in part as it is still incorporated into formulae for
funding calculations. The growth in clients in effective treatment since the previous financial year is
reported in this section, segmented by opiate and non-opiate users.
In treatment
This section focuses on length of time clients have spent in treatment at the partnership and is
intended to give an indication of where clients may be spending longer than is necessary in
treatment. The proportion of clients still in treatment between 4-6 years and longer than 6 years is
reported in this section along with the average length of time in treatment (in years). In treatment
data for Criminal Justice clients is also presented in this section: the proportion of the treatment
population that are criminal justice clients and the average length of time in treatment (in years) are
both reported.
Reduced drug use, housing and employment outcomes
The first four items in this section look at the in-treatment progress regarding drug use and/or
injecting as observed at a review after 6 months in treatment. This is done via the Treatment
Outcomes Profile (TOP) form. The last two items relate to change in clients’ employment and
housing status according to their TOP taken at exit. The TOP Quarterly Outcomes Report provides
more detail on these and other indicators taken from TOP analysis.
Waiting times
This section details the proportions of clients who had to wait longer than 3 weeks to start
treatment. It can provide an early indication of disinvestment as waiting times are one of the first
things to change.
Harm reduction
This section is taken from the quarterly adult performance reports (‘green’ reports) and gives figures
around tests and vaccinations for blood borne viruses, the percentage of eligible new presentations
to treatment who accepted HBV vaccinations and the percentage eligible clients in treatment
previously or currently injecting who received a HCV test.
Parents and families
This section gives an indication of the potential hidden harm suffered by children by identifying
those clients who are parents and/or have children living with them. Figures reported here include
the number of clients in treatment that are living with children and parents that are not living with
children. Also reported are pregnant females newly presenting to treatment in the current financial
year. In addition, re-presentations to treatment are also reported by the three clients groups
previously mentioned.